Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Hematology reference intervals for transgender adults on stable hormone therapy.

Greene DN, McPherson GW, Rongitsch J, Imborek KL, Schmidt RL, Humble RM, Nisly N, Dole NJ, Dane SK, Frerichs J, Krasowski MD.

Clin Chim Acta. 2019 May;492:84-90. doi: 10.1016/j.cca.2019.02.011. Epub 2019 Feb 13.

PMID:
30771301
2.

Comprehensive reference ranges for hematology and clinical chemistry laboratory parameters derived from normal Nigerian adults.

Miri-Dashe T, Osawe S, Tokdung M, Daniel N, Choji RP, Mamman I, Deme K, Damulak D, Abimiku A.

PLoS One. 2014 May 15;9(5):e93919. doi: 10.1371/journal.pone.0093919. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e100601. Daniel, Monday Tokdung Nenbammun [corrected to Tokdung, Monday]; [corrected to Daniel, Nenbammun].

3.

Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study.

Vita R, Settineri S, Liotta M, Benvenga S, Trimarchi F.

Maturitas. 2018 Jan;107:92-96. doi: 10.1016/j.maturitas.2017.10.012. Epub 2017 Oct 16.

PMID:
29169588
4.

Interpreting laboratory results in transgender patients on hormone therapy.

Roberts TK, Kraft CS, French D, Ji W, Wu AH, Tangpricha V, Fantz CR.

Am J Med. 2014 Feb;127(2):159-62. doi: 10.1016/j.amjmed.2013.10.009. Epub 2013 Oct 19.

PMID:
24332725
5.

Low estrogen doses normalize testosterone and estradiol levels to the female range in transgender women.

Cunha FS, Domenice S, Sircili MHP, Mendonca BB, Costa EMF.

Clinics (Sao Paulo). 2018;73:e86. doi: 10.6061/clinics/2018/e86. Epub 2018 May 3.

6.

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.

Karita E, Ketter N, Price MA, Kayitenkore K, Kaleebu P, Nanvubya A, Anzala O, Jaoko W, Mutua G, Ruzagira E, Mulenga J, Sanders EJ, Mwangome M, Allen S, Bwanika A, Bahemuka U, Awuondo K, Omosa G, Farah B, Amornkul P, Birungi J, Yates S, Stoll-Johnson L, Gilmour J, Stevens G, Shutes E, Manigart O, Hughes P, Dally L, Scott J, Stevens W, Fast P, Kamali A.

PLoS One. 2009;4(2):e4401. doi: 10.1371/journal.pone.0004401. Epub 2009 Feb 6.

7.

Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.

Streed CG Jr, Harfouch O, Marvel F, Blumenthal RS, Martin SS, Mukherjee M.

Ann Intern Med. 2017 Aug 15;167(4):256-267. doi: 10.7326/M17-0577. Epub 2017 Jul 25. Review.

PMID:
28738421
8.

Establishment of the hematology reference intervals in a healthy population of adults in the Northwest of Morocco (Tangier-Tetouan region).

Bakrim S, Motiaa Y, Benajiba M, Ouarour A, Masrar A.

Pan Afr Med J. 2018 Mar 23;29:169. doi: 10.11604/pamj.2018.29.169.13042. eCollection 2018.

9.

Barriers to Care Among Transgender and Gender Nonconforming Adults.

Gonzales G, Henning-Smith C.

Milbank Q. 2017 Dec;95(4):726-748. doi: 10.1111/1468-0009.12297.

10.

Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population.

Samaneka WP, Mandozana G, Tinago W, Nhando N, Mgodi NM, Bwakura-Dangarembizi MF, Munjoma MW, Gomo ZA, Chirenje ZM, Hakim JG.

PLoS One. 2016 Nov 3;11(11):e0165821. doi: 10.1371/journal.pone.0165821. eCollection 2016.

11.

Grey and white matter volumes either in treatment-naïve or hormone-treated transgender women: a voxel-based morphometry study.

Spizzirri G, Duran FLS, Chaim-Avancini TM, Serpa MH, Cavallet M, Pereira CMA, Santos PP, Squarzoni P, da Costa NA, Busatto GF, Abdo CHN.

Sci Rep. 2018 Jan 15;8(1):736. doi: 10.1038/s41598-017-17563-z.

12.

Non-Prescribed Hormone Use and Barriers to Care for Transgender Women in San Francisco.

de Haan G, Santos GM, Arayasirikul S, Raymond HF.

LGBT Health. 2015 Dec;2(4):313-23. doi: 10.1089/lgbt.2014.0128. Epub 2015 Aug 31.

PMID:
26788772
13.

Effects of cross-sex hormone treatment on transgender women and men.

Deutsch MB, Bhakri V, Kubicek K.

Obstet Gynecol. 2015 Mar;125(3):605-10. doi: 10.1097/AOG.0000000000000692.

14.

A Structural Magnetic Resonance Imaging Study in Transgender Persons on Cross-Sex Hormone Therapy.

Mueller SC, Landré L, Wierckx K, T'Sjoen G.

Neuroendocrinology. 2017;105(2):123-130. doi: 10.1159/000448787. Epub 2016 Aug 5.

15.

Disparities in Exposure to Intimate Partner Violence Among Transgender/Gender Nonconforming and Sexual Minority Primary Care Patients.

Valentine SE, Peitzmeier SM, King DS, O'Cleirigh C, Marquez SM, Presley C, Potter J.

LGBT Health. 2017 Aug;4(4):260-267. doi: 10.1089/lgbt.2016.0113. Epub 2017 Jul 18.

PMID:
28719246
16.
17.

What has sex got to do with it? The role of hormones in the transgender brain.

Nguyen HB, Loughead J, Lipner E, Hantsoo L, Kornfield SL, Epperson CN.

Neuropsychopharmacology. 2019 Jan;44(1):22-37. doi: 10.1038/s41386-018-0140-7. Epub 2018 Jul 5. Review.

PMID:
30082887
18.

Complete blood count reference intervals for healthy Han Chinese adults.

Wu X, Zhao M, Pan B, Zhang J, Peng M, Wang L, Hao X, Huang X, Mu R, Guo W, Qiao R, Chen W, Jiang H, Ma Y, Shang H.

PLoS One. 2015 Mar 13;10(3):e0119669. doi: 10.1371/journal.pone.0119669. eCollection 2015.

19.

Evaluation of locally established reference intervals for hematology and biochemistry parameters in Western Kenya.

Odhiambo C, Oyaro B, Odipo R, Otieno F, Alemnji G, Williamson J, Zeh C.

PLoS One. 2015 Apr 13;10(4):e0123140. doi: 10.1371/journal.pone.0123140. eCollection 2015.

20.

Urine and Serum Sex Steroid Profile in Testosterone-Treated Transgender and Hypogonadal and Healthy Control Men.

Savkovic S, Lim S, Jayadev V, Conway A, Turner L, Curtis D, Goebel C, Handelsman DJ.

J Clin Endocrinol Metab. 2018 Jun 1;103(6):2277-2283. doi: 10.1210/jc.2018-00054.

PMID:
29584875

Supplemental Content

Support Center